ADIPOPHILIN PEPTIDE (ADPH 129-137) IS NOT A TARGET ANTIGEN FOR CD8⁺ T-CELLS IN PATIENTS WITH OBESITY

Area of Science:

• Immunology
• Metabolic Disorders
• Molecular Biology

Background:

• Obesity is linked to adipose tissue inflammation and insulin resistance.
• Adipophilin (ADPH), involved in lipid droplet regulation, is overexpressed in obesity.
• Leukocyte infiltration in adipose tissue contributes to obesity-related inflammation.

Purpose of the Study:

• To determine if the ADPH 129-137 peptide functions as a target for CD8+ T-cells in obese individuals.
• To assess the role of ADPH as a potential autoantigen in obesity-associated immune responses.

Main Methods:

• Peripheral blood mononuclear cells (PBMCs) were collected from obese patients and healthy controls (HLA-A0201 positive).
• ELISPOT assay was used to detect IFN-γ producing CD8+ T-cells.
• Immune responses were measured against ADPH 129-137 and control peptides (Flu MP58-66, Melan-A27-35).

Main Results:

• No significant difference in CD8+ T-cell response to ADPH 129-137 was observed between obese patients and healthy donors.
• The ELISPOT assay did not reveal a heightened immune reaction against the ADPH peptide in the context of obesity.

Conclusions:

• The ADPH 129-137 peptide does not appear to act as an autoantigen in the studied obese population.
• These findings suggest ADPH may not be a significant target for CD8+ T-cell-mediated autoimmunity in obesity.